| Metric | Q1 2024 | Q4 2023 | Q1 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $689M | — | — | — | — |
| Op. Income | $105M | — | — | — | — |
| Gross Margin | 32.9% | — | — | — | — |
| Net Margin | 13.8% | — | — | — | — |
| EPS (Diluted) | $0.49 | — | — | — | — |
| Free Cash Flow | $59M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $689M |
| Cost of Revenue | $462M |
| GROSS PROFIT | $227M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $56M |
| SG&A Expenses | $56M |
| Other Expenses | $65M |
| Operating Expenses | $121M |
| Cost & Expenses | $584M |
| OPERATING INCOME | $105M |
| Interest Income | $0 |
| Interest Expense | $21M |
| Other Income/Expenses | $300.0K |
| INCOME BEFORE TAX | $106M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $96M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $95M |
| Net Income Deductions | $6M |
| BOTTOM LINE NET INCOME | $85M |
| D&A | $3M |
| EBIT | $126M |
| EBITDA | $129M |
| EPS | $1 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $689M |
| Cost of Revenue | $462M |
| GROSS PROFIT | $227M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $56M |
| SG&A Expenses | $56M |
| Other Expenses | $65M |
| Operating Expenses | $121M |
| Cost & Expenses | $584M |
| OPERATING INCOME | $105M |
| Interest Income | $0 |
| Interest Expense | $21M |
| Other Income/Expenses | $300.0K |
| INCOME BEFORE TAX | $106M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $96M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $95M |
| Net Income Deductions | $6M |
| BOTTOM LINE NET INCOME | $85M |
| D&A | $3M |
| EBIT | $126M |
| EBITDA | $129M |
| EPS | $1 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $95M |
| Depreciation & Amortization | $3M |
| Stock-Based Compensation | $4M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$14M |
| Change in Working Capital | -$29M |
| OPERATING CASH FLOW | $59M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$977M |
| Sales/Maturities of Investments | $856M |
| Other Investing Activities | $41M |
| NET CASH FROM INVESTING | -$81M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$5M |
| NET CASH FROM FINANCING | $7M |
| FREE CASH FLOW | $59M |
| Net Change in Cash | -$15M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $868M |
| Short-Term Investments | $3.0B |
| Net Receivables | $4.4B |
| Inventory | $0 |
| Other Current Assets | -$5.5B |
| TOTAL CURRENT ASSETS | $3.2B |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $150M |
| Long-Term Investments | $6.2B |
| Tax Assets | $0 |
| Other Non-Current Assets | $6.8B |
| TOTAL NON-CURRENT ASSETS | $13.1B |
| TOTAL ASSETS | $13.1B |
| Account Payables | $1.8B |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$1.8B |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $771M |
| Deferred Revenue NC | $26M |
| Deferred Tax Liabilities | $49M |
| Other Non-Current Liabilities | $6.9B |
| TOTAL NON-CURRENT LIABILITIES | $10.5B |
| TOTAL LIABILITIES | $10.5B |
| Common Stock | $17M |
| Additional Paid-In Capital | $1.7B |
| Retained Earnings | $692M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$17M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.6B |
| Minority Interest | $18M |
| TOTAL EQUITY | $2.6B |
| TOTAL LIABILITIES & EQUITY | $13.1B |
| Total Debt | $771M |
| Net Debt | -$97M |
